Dr. Lodge is the Chief Science and Innovation Officer at Cellero. She has a strong background in cell-based therapeutics and immunology, including a Ph.D. in Cell and Molecular Biology from the University of Vermont and a postdoctoral fellowship with the Multiple Sclerosis Society studying the role of T cells in the disease process. Learn more about Dr. Lodge.

NY-ESO-1-Specific T Cell Lines Now Available for Cancer Immunotherapy Research

After launching our first tumor-specific T cell line (anti-leukemia / WT-1 T cells) in November, we now have another exciting tumor-specific T cell line in our catalog: Anti-NY-ESO-1 T Cells! Applications for NY-ESO-1 Immunotherapies The NY-ESO-1 (New York Esophageal Squamous Cell Carcinoma 1) antigen is restricted to germ and placental cells, with re-expression in tumor…

Useful Tools in Immunology: The Immune Epitope Database

The Immune Epitope Database (IEDB) is a free online resource established by the National Institute for Health. The IEDB makes it easy for scientists and researchers to search for experimental data characterizing antibody and T cell epitopes for allergens, infectious diseases, autoimmune diseases, and transplants/alloantigens. Beyond epitope search, the IEDB also offers unique epitope analysis…

Immunology for Non-Immunologists: Challenges and Opportunities with Influenza Virus

Influenza is a complex, unpredictable virus that has kept scientists searching for more universal vaccinations and treatments to the deadly disease. Two mechanisms render the immune system ineffective in fighting the influenza virus: antigenic drift and antigenic shift. Antigenic Drift: Due to the lack of RNA proofreading enzymes, influenza virus genomes can accumulate mutations through…